Back to Authors

Colbenson, Kristina M.

Mayo Clinic

Mayo Clinic

Citations 5

American Medical Society for Sports Medicine Orthobiologics Toolkit for Sports Medicine Fellowships
Poindexter, Lauren K. , Nye, Nathaniel S., Romero, Joshua , Olufade, Oluseun A., Roh, Eugene Y. , Johnson, Shelby E. , Denq, William , Colbenson, Kristina M., Kruse, Ryan, Borg-Stein, Joanne, Romero, J. García , Colbenson, Kristina, Romero, Joshua M , Mautner, Kenneth , Olufade, Oluseun A., Kruse, Ryan C. , Shapiro, Shane A. , Borg‐Stein, Joanne

Clinical Journal of Sport Medicine | February 4, 2026 | Volume: 36 | Issue: 2 | Pages: 185-194

10.1097/jsm.0000000000001418 Get It

Objective: Orthobiologics are increasingly sought-after interventions in sports medicine for treatment of musculoskeletal injuries and conditions. Despite this trend, differences exist across sports medicine fellowship programs regarding foundational knowledge, educational curricula, and practical experience with orthobiologic therapies (eg, platelet-rich plasma, bone marrow aspirate concentrate, microfragmented adipose tissue). This represents an important educational gap for those training in sports medicine fellowships. To address this gap, an educational toolkit was envisioned with the sports medicine fellowship director and trainee in mind. Data Sources: Collective observations from physician experts in sports medicine education established the variations in curricula and expertise of graduating fellows. A literature review was conducted to source English-language peer reviewed articles from the online PubMed database. The scope of this project did not include an independent systematic analysis or statistical assessments. Main Results: An educational toolkit consisting of 12 adaptable modules was developed, each with a suggested reading list from the published literature. The modules may be rearranged to support each program's learning schedule. The information and lessons contained herein may be valuable to all healthcare providers interested in the evidence-based application of orthobiologics and insightful interpretation of related research. Conclusions: By implementing an educational toolkit, sports medicine fellowships may improve the quality of education on orthobiologics. This is intended to improve the knowledge and skill set of fellowship graduates, thus promoting the scientific, responsible use of orthobiologic interventions.
Tranexamic Acid Administered at Time of Hospital Admission Does Not Decrease Transfusion Rates or Blood Loss for Extracapsular Hip Fractures: A Double-Blinded Randomized Clinical Trial
Owen, Aaron R. , Boe, Chelsea C., Kuttner, Nicolas P. , Cancio-Bello, Alexandra , Colbenson, Kristina M., Cross, William W., Sems, S.A. , Yuan, Brandon J. , Cancio-Bello, Alexandra M, Yuan, Brandon , Hidden, Krystin A. , Barlow, Jonathan D.

Journal of Orthopaedic Trauma | July 9, 2024 | Volume: 38 | Issue: 10 | Pages: 515-520

10.1097/bot.0000000000002870 Get It

OBJECTIVES: To evaluate tranexamic acid (TXA) when administered immediately on hospital presentation in patients with extracapsular peritrochanteric hip fractures to determine its effect on (1) transfusion rates, (2) estimated blood loss, and (3) complications. METHODS: Design: Prospective, double-blinded, randomized clinical trial. Setting: Single-center, Level 1 trauma center. Patient Selection Criteria: All patients with isolated OTA/AO 31-A fracture patterns from 2018 to 2022 were eligible for inclusion. Study drug was administered in the emergency department at the time of presentation—1-g bolus over 10 minutes followed by a 1-g infusion over 8 hours. Outcome Measures and Comparisons: The primary outcome was the rate of red blood cell transfusion hospital days 1–4. Secondary outcomes included estimated blood loss and complications including venous thromboembolic events, stroke, myocardial infarction, all-cause 90-day readmissions, and all-cause mortality. RESULTS: One hundred twenty-eight patients were included—64 patients were randomized to intravenous TXA and 64 patients to intravenous normal saline (ie, placebo). There was no difference in the rate of red blood cell transfusion between treatment arms between hospital days 1–4 (27% in the TXA arm vs. 31% in the placebo arm, P = 0.65). Patients randomized to placebo who required transfusion received a mean of 2.30 units compared with 1.94 units in the TXA cohort (P = 0.55). There was no difference in the estimated blood loss between hospital days 1–4. There was no difference in the incidence of postoperative complications including venous thromboembolic events, stroke, myocardial infarction, 90-day readmission, or death. CONCLUSIONS: The results of this study do not support the use of preoperative TXA for reducing blood loss for geriatric patients with extracapsular hip fractures. LEVEL OF EVIDENCE: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
Charting Practices to Protect Against Malpractice: Case Reviews and Learning Points
Ghaith, Summer , Colbenson, Kristina M., Lindor, Rachel A. , Moore, Gregory P. , Lindor, Rachel A , Moore, Gregory Martin

Western Journal of Emergency Medicine | May 25, 2022 | Volume: 23 | Issue: 3 | Pages: 412-417

10.5811/westjem.2022.1.53894 Get It

Introduction: Medical documentation issues play a role in 10-20% of medical malpractice lawsuits. Inaccurate, incomplete, or generic records undermine a physician’s defense and make a plaintiff’s lawyer more likely to take on a case. Despite the frequency of documentation errors in malpractice suits, physicians receive very little education or feedback on their documentation. Our objective in this case series was to evaluate malpractice cases related to documentation to help improve physicians’ documentation and minimize their liability risks. Methods: We used Thomson Reuters Westlaw legal database to identify malpractice cases related to documentation. Common issues related to documentation and themes in the cases were identified and highlighted. Results: We classified cases into the following categories: incomplete documentation; inaccurate text; transcription errors; judgmental language; and alteration of documentation. By evaluating real cases, physicians can better understand common errors of other practitioners and avoid these in their own practice. Conclusion: Emergency physicians can reduce their liability risks by relying less on forms and templates and making a habit of documenting discussions with the patients, recording others’ involvement in patient care (chaperones, consultants, trainees, etc.), addressing others’ notes (triage staff, nurses, residents, etc.), paying attention to accuracy of transcribed or dictated information, avoiding judgmental language, and refraining from altering patient charts.
Efficacy of empiric antibiotic therapy without aspiration for septic prepatellar bursitis in emergency department patients
Thomas, Alexa , Beyde, Adrian , Sandefur, Benjamin J. , Colbenson, Kristina M., Kisirwan, Imtithal, Finley, Anissa L., Krych, Aaron J. , Campbell, Ronna L. , Thomas, Alexa L , Campbell, Ronna L , Krych, Aaron J , Finley, Anissa , Mullan, Aidan F.

Academic Emergency Medicine | April 5, 2022 | Volume: 29 | Issue: 8 | Pages: 1027-1032

10.1111/acem.14499 Get It

Efficacy of empiric antibiotic management of septic olecranon bursitis without bursal aspiration in emergency department patients
Beyde, Adrian , Thomas, Alexa , Colbenson, Kristina M., Sandefur, Benjamin J. , Kisirwan, Imtithal, O’Driscoll, Shawn W. , Thomas, Alexa L, O'Driscoll, Shawn W., Campbell, Ronna L. , Fitzsimmons, James S , Thomas, Alexa L , Mullan, Aidan F.

Academic Emergency Medicine | October 26, 2021 | Volume: 29 | Issue: 1 | Pages: 6-14

10.1111/acem.14406 Get It

AbstractObjectivesMany guidelines for septic olecranon bursitis recommend aspiration of the bursa prior to initiation of antimicrobial therapy despite the absence of robust clinical data to support this practice and known risk of aspiration complications. Our objective was to describe outcomes associated with empiric antibiotic therapy without bursal aspiration among emergency department (ED) patients with suspected septic olecranon bursitis.MethodsWe conducted a retrospective observational cohort study of patients presenting to an academic ED from January 1, 2011, to December 31, 2018, with olecranon bursitis. The health record was reviewed to assess patient characteristics and outcomes within 6 months of the ED visit. Olecranon bursitis was considered “suspected septic” if the patient was treated with antibiotics. The primary outcome of interest was complicated versus uncomplicated bursitis resolution. Uncomplicated resolution was defined as bursitis resolution without subsequent bursal aspiration, surgery, or hospitalization.ResultsDuring the study period, 264 ED patients were evaluated for 266 cases of olecranon bursitis. The median age was 57 years and 85% were men. Four (1.5%) patients had bursal aspiration during their ED visit, 39 (14.7%) were admitted to the hospital, 76 (28.6%) were dismissed without antibiotic therapy, and 147 (55.3%) were dismissed with empiric antibiotic therapy for suspected septic olecranon bursitis. Among these 147 patients, 134 had follow‐up available including 118 (88.1%, 95% confidence interval [CI] = 81.1%–92.8%) with an uncomplicated resolution, eight (6.0%, 95% CI = 2.8%–11.8%) who underwent subsequent bursal aspiration, and nine (6.7%, 95% CI = 3.3%–12.7%) who were subsequently admitted for inpatient antibiotics.ConclusionsEighty‐eight percent of ED patients with suspected septic olecranon bursitis treated with empiric antibiotics without aspiration had resolution without need for subsequent bursal aspiration, hospitalization, or surgery. Our findings suggest that empiric antibiotics without bursal aspiration may be a reasonable initial approach to ED management of select patients with suspected septic olecranon bursitis.